You are viewing the site in preview mode
Skip to main content
|
Features
|
MVI-(n = 41/43)
|
MVI + (n = 19/19)
|
p Value
|
|---|
|
Sex
| | |
0.276
|
|
Man
|
30 (73.2%)
|
17 (89.5%)
| |
|
Woman
|
11 (26.8%)
|
2 (10.5%)
| |
|
Age (year)
| | |
0.116
|
|
< 52
|
30 (50%%)
|
10 (16.7%)
| |
|
3 52
|
11 (18.3%)
|
9 (15%)
| |
|
History of drinking
| | |
0.813
|
|
Yes
|
12 (29.3%)
|
5 (26.3%)
| |
|
No
|
29 (70.7%)
|
14 (73.7%)
| |
|
History of smoking
| | |
0.985
|
|
Yes
|
15 (36.6%)
|
7 (36.8%)
| |
|
No
|
26 (63.4%)
|
12 (63.2%)
| |
|
Cirrhosis
| | |
0.287
|
|
Yes
|
32 (78.0%)
|
17 (89.5%)
| |
|
No
|
9 (22.0%)
|
2 (10.5%)
| |
|
CEA (ng/ml)
| | |
0.908
|
|
> 5
|
2 (3.6%)
|
1 (1.7%)
| |
|
< 5
|
37 (66.1%)
|
16 (28.6%)
| |
|
Ca199 (u/ml)
| | |
0.528
|
|
> 40
|
6 (10.5%)
|
4 (7%)
| |
|
= S40
|
33 (57.9%)
|
14 (24.6%)
| |
|
AFP (ng/ml)
| | |
0.094
|
|
> 25
|
15 (25.9%)
|
11 (19.0%)
| |
| |
25 (43.1%)
|
7 (12.1%)
| |
|
ALT (u/l)
| | |
0.003
|
|
> 40
|
5 (8.3%)
|
9 (15%)
| |
|
< 40
|
36 (60%)
|
10 (16.6%)
| |
|
AST (u/l)
| | | |
|
> 35
|
12 (20%)
|
9 (15%)
|
0.172
|
|
< 35
|
29 (48.3%)
|
10 (16.7%)
| |
|
GGT (u/l)
| | |
0.052
|
|
> 40
|
17 (28.3%)
|
13 (21.7%)
| |
|
< 40
|
24 (40%)
|
6 (10%)
| |
|
Albumin (g/l)
| | |
1.000
|
|
< 40
|
29 (48.3%)
|
13 (21.7%)
| |
|
> 40; < 55
|
12 (20%)
|
6 (10%)
| |
|
> 55
|
0 (0%)
|
0 (0%)
| |
|
HBV
| | |
0.061
|
|
Yes
|
22 (53.7%)
|
15 (78.9%)
| |
|
No
|
19 (46.3%)
|
4 (21.1%)
| |
|
Pathology classification
| | |
0.003
|
|
Low
|
1 (2.3%)
|
6 (31.6%)
| |
|
Medium
|
23 (53.5%)
|
8 (42.1%)
| |
|
High
|
19 (44.2%)
|
5 (26.3%)
| |
|
Tumor size (cm)
| | |
0.065
|
|
> 2.75
|
19 (31.7%)
|
10 (16.6%)
| |
|
< 2.75
|
22 (36.7%)
|
9 (15%)
| |
- Except where indicated otherwise, data are number (%) of patients. Categoric imaging variables were analyzed by the chi-square test. CEA, carcinoembryonicantigen; CA199, carbohydrate antigen 199; AFP, alpha-fetoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamm glutamyl transferase; HBV, hepatitis B virus
